Kristiansen IS - Search Results

1

Different ways to describe the benefits of risk-reducing treatments: a randomized trial.

Halvorsen PA, Selmer R, Kristiansen IS. Halvorsen PA, et al. Among authors: kristiansen is. Ann Intern Med. 2007 Jun 19;146(12):848-56. doi: 10.7326/0003-4819-146-12-200706190-00006. Ann Intern Med. 2007. PMID: 17577004 Clinical Trial.

2

Anticipated longevity among lay people screened for cardiovascular risk factors: a cross-sectional questionnaire study.

Halvorsen PA, Selmer RM, Kristiansen IS. Halvorsen PA, et al. Among authors: kristiansen is. Scand J Public Health. 2010 Jul;38(5):481-8. doi: 10.1177/1403494810370235. Epub 2010 May 28. Scand J Public Health. 2010. PMID: 20511321

3

Laypersons' understanding of relative risk reductions: randomised cross-sectional study.

Sorensen L, Gyrd-Hansen D, Kristiansen IS, Nexøe J, Nielsen JB. Sorensen L, et al. Among authors: kristiansen is. BMC Med Inform Decis Mak. 2008 Jul 17;8:31. doi: 10.1186/1472-6947-8-31. BMC Med Inform Decis Mak. 2008. PMID: 18631406 Free PMC article.

4

Communicating effectiveness of intervention for chronic diseases: what single format can replace comprehensive information?

Stovring H, Gyrd-Hansen D, Kristiansen IS, Nexoe J, Nielsen JB. Stovring H, et al. Among authors: kristiansen is. BMC Med Inform Decis Mak. 2008 Jun 19;8:25. doi: 10.1186/1472-6947-8-25. BMC Med Inform Decis Mak. 2008. PMID: 18565218 Free PMC article. Clinical Trial.

5

Joint and separate evaluation of risk reduction: impact on sensitivity to risk reduction magnitude in the context of 4 different risk information formats.

Gyrd-Hansen D, Halvorsen P, Nexøe J, Nielsen J, Støvring H, Kristiansen I. Gyrd-Hansen D, et al. Med Decis Making. 2011 Jan-Feb;31(1):E1-10. doi: 10.1177/0272989X10391268. Epub 2010 Dec 20. Med Decis Making. 2011. PMID: 21173438 Clinical Trial.

6

Threats from patients and their effects on medical decision making: a cross-sectional, randomised trial.

Kristiansen IS, Førde OH, Aasland O, Hotvedt R, Johnsen R, Førde R. Kristiansen IS, et al. Lancet. 2001 Apr 21;357(9264):1258-61. doi: 10.1016/S0140-6736(00)04407-X. Lancet. 2001. PMID: 11418151 Clinical Trial.

7

Cost effectiveness of replacing diclofenac with a fixed combination of misoprostol and diclofenac in patients with rheumatoid arthritis.

Kristiansen IS, Kvien TK, Nord E. Kristiansen IS, et al. Arthritis Rheum. 1999 Nov;42(11):2293-302. doi: 10.1002/1529-0131(199911)42:11<2293::AID-ANR6>3.0.CO;2-1. Arthritis Rheum. 1999. PMID: 10555023

8

Influence of number needed to treat, costs and outcome on preferences for a preventive drug.

Nexøe J, Kristiansen IS, Gyrd-Hansen D, Nielsen JB. Nexøe J, et al. Among authors: kristiansen is. Fam Pract. 2005 Feb;22(1):126-31. doi: 10.1093/fampra/cmh706. Epub 2005 Jan 7. Fam Pract. 2005. PMID: 15640298 Clinical Trial.

9

Number needed to treat: easily understood and intuitively meaningful? Theoretical considerations and a randomized trial.

Kristiansen IS, Gyrd-Hansen D, Nexøe J, Nielsen JB. Kristiansen IS, et al. J Clin Epidemiol. 2002 Sep;55(9):888-92. doi: 10.1016/s0895-4356(02)00432-8. J Clin Epidemiol. 2002. PMID: 12393076

10

Number-needed-to-treat (NNT)--needs treatment with care.

Christensen PM, Kristiansen IS. Christensen PM, et al. Among authors: kristiansen is. Basic Clin Pharmacol Toxicol. 2006 Jul;99(1):12-6. doi: 10.1111/j.1742-7843.2006.pto_412.x. Basic Clin Pharmacol Toxicol. 2006. PMID: 16867164 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results